Home Cart Sign in  
Chemical Structure| 179474-85-2 Chemical Structure| 179474-85-2

Structure of Prucalopride succinate
CAS No.: 179474-85-2

Chemical Structure| 179474-85-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Prucalopride Succinate is a selective and high-affinity 5-HT4 receptor agonist with enterokinetic activities.

Synonyms: R-108512

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Prucalopride succinate

CAS No. :179474-85-2
Formula : C22H32ClN3O7
M.W : 485.96
SMILES Code : O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC3CCN(CCCOC)CC3.O=C(O)CCC(O)=O
Synonyms :
R-108512
MDL No. :MFCD00948731
InChI Key :QZRSNVSQLGRAID-UHFFFAOYSA-N
Pubchem ID :9870009

Safety of Prucalopride succinate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Prucalopride succinate

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages (BMDM) 150 µM Evaluate the effect of PRUC on ATP-induced macrophage activation, showing that PRUC mimicked the inhibitory effect of electrical field stimulation PMC6691854

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Postoperative ileus model Oral gavage 1 or 5 mg/kg Single dose 1.5 hours before or 22.5 hours after surgery Evaluate the effect of PRUC on postoperative ileus, showing that preoperative administration reduced intestinal inflammation and improved gut transit, while postoperative administration was ineffective PMC6691854
C57BL/6j mice Alzheimer's disease model Subcutaneous injection 5 or 10 mg/kg Single injection, analyzed after 90 minutes To investigate the effect of 5-HT4 receptor agonists on sAPPα levels, results showed that prucalopride significantly increased sAPPα levels in the hippocampus and cortex. PMC2013878
Male C57BL/6J mice DSS-induced colitis model Oral 5 mg/kg Once daily for 7 days Restored small intestinal motility and attenuated colitis PMC11127033
C57BL/6 mice MPTP-induced Parkinson’s disease model mice Intraperitoneal injection 1.5 or 3 mg/kg Administered 2 h before each training session, twice in total To investigate the effects of 5-HT4 receptor agonists on contextual fear extinction in PD mice, results showed that prucalopride succinate prevented the facilitation of contextual fear extinction in PD mice in a dose-dependent manner, but had no significant effect on control mice. PMC6862438
Mice 129S6/SvEv mice Injection 3 or 10 mg/kg Single injection, experiments conducted one week later Prucalopride attenuated learned fear and decreased stress-induced depressive-like behavior PMC6969048
Mice PS19 mice (tauopathy model) Intraperitoneal injection 3 mg/kg Twice daily for 6 weeks To evaluate the effect of 5-HT4R agonists on tau pathology. Results showed that prucalopride succinate and RS-67333 significantly reduced tau phosphorylation and aggregation, and improved cognitive function. PMC11024353

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.29mL

2.06mL

1.03mL

20.58mL

4.12mL

2.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories